newdrugapprovals.org
FDA Approves Spiriva Respimat (tiotropium) for the Maintenance Treatment of COPD
Ridgefield, Conn., September 25, 2014 – Boehringer Ingelheim Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) approved Spiriva Respimat (tiotropium bromide) in…